OptimizeRx Corporation (OPRX)
Automate Your Wheel Strategy on OPRX
With Tiblio's Option Bot, you can configure your own wheel strategy including OPRX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OPRX
- Rev/Share 5.1089
- Book/Share 6.2948
- PB 2.2527
- Debt/Equity 0.2821
- CurrentRatio 2.8179
- ROIC -0.0675
- MktCap 262260518.0
- FreeCF/Share 0.3417
- PFCF 41.5561
- PE -16.9987
- Debt/Assets 0.1955
- DivYield 0
- ROE -0.1315
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | OPRX | RBC Capital Mkts | Outperform | Sector Perform | $7 | $6 | Jan. 8, 2025 |
| Initiation | OPRX | Stephens | -- | Equal Weight | -- | $5.5 | Dec. 20, 2024 |
News
Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Does OptimizeRx Corp. (OPRX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
OptimizeRx (OPRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
OptimizeRx to Participate in Upcoming Investor Conferences
Published: May 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
WALTHAM, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will participate in the following upcoming investor conferences:
Read More
OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
Published: March 12, 2025 by: Seeking Alpha
Sentiment: Neutral
OptimizeRx Corporation (NASDAQ:OPRX ) Q4 2024 Results Conference Call March 12, 2025 8:30 AM ET Company Participants Steve Silvestro - President Edward Stelmakh - Chief Financial Officer and Chief Operational Officer Andrew D'Silva - Senior Vice President of Corporate Finance Conference Call Participants Jared Haase - William Blair Anderson Schock - B. Riley Constantine Davides - Citizens JMP Richard Baldry - ROTH Capital David Grossman - Stifel Financial Eric Martinuzzi - Lake Street Jeff Garro - Stephens, Inc Operator Good morning, everyone, and thank you for joining OptimizeRx's Fourth Quarter and Full Year Fiscal 2024 Earnings Conference Call.
Read More
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.26 per share a year ago.
Read More
About OptimizeRx Corporation (OPRX)
- IPO Date 2007-11-28
- Website https://www.optimizerx.com
- Industry Medical - Healthcare Information Services
- CEO Mr. Stephen L. Silvestro
- Employees 128